A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
Clinical trial NCT05099848 · COMPLETED
Trial details
- NCT number
- NCT05099848
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2024-01-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.